D. Ross Camidge

D. Ross Camidge Discusses Brain Metastases in Patients With Lung Cancer

August 25, 2015

Article

D. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the need for more research into brain metastases in lung cancer patients.

D. Ross Camidge on the Development of a New Lung Cancer Drug

August 24, 2015

Article

D. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the development of brigatinib, an oral inhibitor of anaplastic lymphoma kinase (ALK).